[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"learn-detail:webinars:navigating-the-tga-legal-landscape-medicinal-cannabis-prescribing":3},{"id":4,"slug":5,"title":6,"excerpt":7,"image_url":8,"cpd_points":9,"duration_minutes":10,"starts_at":11,"type":12,"hero_image_url":13,"body_html":7,"learning_outcomes":14,"learning_outcomes_heading":19,"about":20,"speakers":23,"cta":31,"sponsors":35,"cpd_activity":66,"related":69},"41","navigating-the-tga-legal-landscape-medicinal-cannabis-prescribing","Navigating the TGA Legal Landscape: Medicinal Cannabis Prescribing","With evolving regulations and heightened scrutiny on medicinal cannabis prescriptions, it’s crucial for doctors to stay up to date with TGA guidelines and legal requirements.","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fwebinars\u002FWebinar_2025_02_11_COVER_OVERLAY.webp",1,94,"2025-02-18T19:00:00+11:00","webinars","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fwebinars\u002Fhero-images\u002FWebinar_2025_02_11_HERO_OVERLAY.webp",[15,16,17,18],"Explain the TGA Special Access Scheme and Authorised Prescriber pathways for medicinal cannabis.","Create TGA-compliant prescriptions, taking into account flower limits and patient assessments","Identify the legal implications of non-compliance and learn strategies to avoid overprescribing and other regulatory breaches","Identify patients at risk of drug dependence and engage with appropriate drug dependence programs and authorisations.","Learning Outcomes",{"heading":21,"body_html":22},"About the webinar","With evolving regulations and heightened scrutiny on medicinal cannabis prescriptions, it’s crucial for doctors to stay up to date with TGA guidelines and legal requirements. This webinar, presented by Dr. Danny Cai, will provide an in-depth look at the current TGA legal landscape for medicinal cannabis prescribing. It will cover best practices for compliance, writing prescriptions, managing flower limits, and handling patients at risk of drug dependence. With recent industry changes, now is the time to ensure your practice adheres to the latest regulatory standards.",{"heading":24,"items":25},"About the speaker",[26],{"name":27,"position":28,"bio_html":29,"image_url":30},"Dr Danny Cai","Educator","Dr. Cai is a highly accomplished medical professional with over 20 years of clinical experience, including a deep passion for the transformative potential of medical cannabis. As a Fellow of the Royal Australian College of General Practitioners (FRACGP), he has developed extensive expertise in clinical care, healthcare governance, strategic operations, and compliance.\r\n\r\nWith over five years of dedicated experience in the medical cannabis field, Dr. Cai is committed to advancing this area of healthcare, ensuring it is compliant with the highest standards, and delivering holistic, patient-centered care. His role as a federal government consultant and former medical officer of the Commonwealth further underscores his active involvement in shaping public health policy and reform.","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fwebinars\u002Fspeakers\u002FDanny_Cai.png",{"published":32,"on_demand":33,"is_free":33,"price":34},false,true,0,[36,41,45,50,54,58,62],{"name":37,"logo_url":38,"level":39,"website_url":40},"Tilray Australia","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fsponsors\u002Flogos\u002FTilray-logo.png","premium","https:\u002F\u002Fwww.tilray.com.au",{"name":42,"logo_url":43,"level":39,"website_url":44},"Cannatrek","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fsponsors\u002Flogos\u002Fcannatrek-logo (2).png","https:\u002F\u002Fcannatrek.com.au",{"name":46,"logo_url":47,"level":48,"website_url":49},"Australian Natural Therapeutics Group","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fsponsors\u002Flogos\u002FANTG.jpg","basic","https:\u002F\u002Faustraliannatural.com",{"name":51,"logo_url":52,"level":48,"website_url":53},"Beacon Medical Australia","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fsponsors\u002Flogos\u002FBeacon-Medical-Logo.png","https:\u002F\u002Fwww.beaconmedical.com.au",{"name":55,"logo_url":56,"level":48,"website_url":57},"ECS Botantics","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fsponsors\u002Flogos\u002FAVANI_LOGO_GOLD (3).png","https:\u002F\u002Fecs-botanics.com",{"name":59,"logo_url":60,"level":48,"website_url":61},"SomaÍ Pharmaceuticals","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fsponsors\u002Flogos\u002FSomai_Logo2.png","https:\u002F\u002Fsomaipharma.com.au",{"name":63,"logo_url":64,"level":48,"website_url":65},"Little Green Pharma","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fsponsors\u002Flogos\u002FLittle-Green-Pharma-logo.jpg","https:\u002F\u002Fwww.littlegreenpharma.com",{"description_html":67,"badge_url":68},"Medihuanna is a CPD approved education provider, and this activity has been approved by the RACGP (Activity ID: 1081878). Upon completing this activity, you will be eligible to claim CPD hours. The activity will include the following CPD allocation which will be uploaded to the RACGP dashboard.","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fwebinars\u002Fbadges\u002FCPD_Approved_Activity_EA_1_25_02_11.jpeg",[70,77,84,91],{"id":71,"slug":72,"title":73,"excerpt":74,"image_url":75,"cpd_points":9,"starts_at":76,"type":12},"50","pastilles-in-clinical-practice","Pastilles in Clinical Practice: Optimising Precision Dosing, Adherence and Patient Outcomes","Explore the clinical role of cannabis pastilles, including precision dosing, patient selection, adherence, safety and the evolving evidence for major and minor cannabinoids.","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fwebinars\u002FCover_Pastilles-80.webp","2026-11-19T19:00:00+11:00",{"id":78,"slug":79,"title":80,"excerpt":81,"image_url":82,"cpd_points":9,"starts_at":83,"type":12},"52","beyond-the-dose-understanding-oral-cannabinoid-therapy","Beyond the Dose: Understanding Oral Cannabinoid Therapy","Explore how formulation, absorption and metabolism influence the bioavailability and clinical effects of oral THC and CBD. This webinar examines key pharmacokinetic principles, emerging delivery technologies and published evidence to inform formulation selection, dosing and patient monitoring.","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fwebinars\u002FBeyond_the_Dose_A.webp","2026-12-02T19:00:00+11:00",{"id":85,"slug":86,"title":87,"excerpt":88,"image_url":89,"cpd_points":9,"starts_at":90,"type":12},"51","emerging-therapeutics-for-bpsd","Emerging Therapeutics for Behavioural and Psychological Symptoms of Dementia","Explore evidence-based management of behavioural and psychological symptoms of dementia and the emerging role of cannabinoid-based medicines.","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fwebinars\u002FCover_Emerging_Dementia-80.webp","2026-10-29T19:00:00+11:00",{"id":92,"slug":93,"title":94,"excerpt":95,"image_url":96,"cpd_points":9,"starts_at":97,"type":12},"49","thcv-and-metabolic-health","THCV and Metabolic Health: Exploring the Evidence and Clinical Potential","Explore the emerging role of Δ9-tetrahydrocannabivarin (THCV) in metabolic health, including its potential influence on appetite regulation, glucose metabolism and weight management. This session reviews THCV pharmacology, CB1 signalling, current preclinical and human evidence, and the key limitations shaping its potential future clinical application.","https:\u002F\u002Fdash.medihuanna.com\u002Fstorage\u002Fwebinars\u002FTHCV_Metabolic_overl-80.jpg","2026-08-27T19:00:00+10:00"]